About Us
Main Menu
About Us
Services
Contact
File Library
Login Form
Username

Password

Remember me
Forgotten your password?
No account yet? Create one
About Us
Dr. Albert P. Li has over 30 years of experience in drug discovery and development. He was one of the pioneers in the application of in vitro systems in the evaluation of drug properties. He co-developed the CHO/HGPRT gene mutation system for industrial applications early in his career in Oak Ridge National Laboratory, Lovelace Inhalation Toxicology Research Institute and Monsanto Company. He was one of the pioneers in the application of human hepatocytes in the evaluation of drug metabolism, drug-drug interactions, and drug toxicity.

Dr. Li was previously Senior Fellow of Monsanto Company, one of the highest technical level in the company; Professor and Director of the Surgical Research Institute, Department of Surgery, St. Louis University Medical School; Chief Scientific Officer of In Vitro Technologies, Inc., a Baltimore-based in vitro contract research and products company; and President and C.E.O. of Phase-1 Molecular Toxicology, Inc., a toxicogenomics company based in Santa Fe, New Mexico. Dr. Li founded APSciences in October, 2003.

Dr. Li has over 150 peer-reviewed publications and have edited 5 books and 4 special journal issues in the area of drug development. Dr. Li is current editor of the Hepatocyte Reports of Chemico-Biological Interactions.